Dr. Michael Scott Berlowitz, MD

Dr. Berlowitz practices at Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services.

Dr. Berlowitz's NPI, 1902871817, was assigned on February 22, 2006. Dr. Berlowitz graduated from University Of Michigan Medical School in 1995. Dr. Berlowitz holds Maine license MD24894.

Dr. Berlowitz's primary practice is Central Maine Medical Center, at 300 Main Street, Lewiston, ME 04240 in Androscoggin County. The practice phone is (207) 795-0111.

Dr. Berlowitz's primary practice is Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services. Dr. Berlowitz is also affiliated with Bridgton Hospital. The medical group on file is Central Maine Medical Center. Dmand AI also links Dr. Berlowitz to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account. Dr. Berlowitz's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berlowitz practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Berlowitz's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Berlowitz is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Berlowitz's licenses on file in 4 states: Maine, Florida, New York and Georgia.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Dr. Berlowitz treats.

CMS data shows 741 Medicare services from Dr. Berlowitz across 8 procedure codes in 2024, for 499 Medicare patients. Medicare paid $30,252 for them.

CMS counts 499 Medicare patients who saw Dr. Berlowitz in 2024. The largest group is 75 to 84, with 152 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berlowitz's median patient age at 73, with 44% women.

In 2024, Dr. Berlowitz wrote 1,070 Medicare Part D claims for 210 patients. 83% of them were for generic drugs. CMS names the drug for 981 of them, across 25 drugs with 11 or more claims each, at $127,940 in total drug cost. In 2023, CMS named 506 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Berlowitz for performance year 2024, reported as part of a group. Dr. Berlowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Berlowitz, published from 2011 to 2019. 2018 was the busiest year, with 2. The most frequent topics are Antihypertensive Agents, Tetrazoles and Angiotensin Receptor Antagonists. Dr. Berlowitz's most frequent co-authors are Sanders Honggook Chae, MD, Farhana Latif, MD and Christopher J. Bitetzakis, DO.

CMS Open Payments shows 28 general payments to Dr. Berlowitz from 10 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 63% of the total. Abbott Laboratories paid the most, $1,744.

Dmand AI lists 2 awards for Dr. Berlowitz, most recently CMS Stage 1 EHR in 2013.

Dr. Berlowitz graduated from University Of Michigan Medical School in 1995. Dr. Berlowitz is a member of ACC.

Dr. Berlowitz is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.